Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Terminated 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

CNS 4Lymphoid 1

Conditions

Urinary Bladder Neoplasms 13Glioblastoma 4Brain Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Glioma 2Astrocytoma 2Urothelial Carcinoma of the Bladder 1Prostatic Hyperplasia 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Urothelial Carcinoma 1Non-Muscle Invasive Bladder Neoplasms 1Neuroblastoma 1Nasopharyngeal Carcinoma 1Muscle-invasive Urothelial Cancer of the Bladder 1Mouth Neoplasms 1Lymphoma, Follicular 1Lung Neoplasms 1Laryngeal Neoplasms 1Ganglioneuroblastoma 1Estrogen Receptor Positive Breast Cancer 1Ependymoma 1Craniopharyngioma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Temozolomide 393Radiotherapy 196Bevacizumab 156Radiation 77Magnetic Resonance Spectroscopy 68Lomustine 47Surgical Procedures, Operative 42Carmustine 41pembrolizumab 39Irinotecan 38Nivolumab 32Specimen Handling 27Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Drug Therapy 20Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13poly ICLC 12atezolizumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Glioblastoma × Transurethral Resection of Bladder × Clear all
NCT06805305 2026-04-23

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Diakonos Oncology Corporation

Phase 2 Recruiting
180 enrolled
CNS

Glioblastoma

NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Mayo Clinic

Phase 1/2 Not yet recruiting
33 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

NCT04221503 2026-01-08

Niraparib/TTFields in GBM

Abramson Cancer Center at Penn Medicine

Phase 2 Active not recruiting
30 enrolled
CNS

Glioblastoma

NCT02722512 2025-02-18

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Terminated
10 enrolled
CNS

Astrocytoma, Ependymoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡